BioSig Technologies Finalizes Share Exchange with Streamex to Pioneer Real-World Asset Tokenization
Deal News | May 24, 2025 | Globenewswire
BioSig Technologies, a medical technology company, has signed a definitive share exchange agreement with Streamex Exchange Corporation, a company that specializes in the tokenization of real-world assets, particularly commodities. This agreement will make Streamex a wholly owned subsidiary of BioSig, with the goal of bringing commodities on-chain. The transaction aims to enable substantial growth and innovation in real-world asset tokenization and will result in Streamex shareholders receiving 75% of BioSig's fully diluted common stock. The combined company will be led by Streamex's CEO, Henry McPhie, and will seek shareholder approval to finalize the exchange. Key strategic advisors have joined to guide the venture's progress in US capital markets. The initiative represents a strategic pivot for BioSig, poised to unlock significant value in the $142.85 trillion global commodity market by integrating blockchain technologies into commodity finance.
Sectors
- Medical Technology
- Blockchain and Cryptocurrency
- Commodity Markets
- Finance
Geography
- United States – BioSig Technologies is based in Los Angeles, CA, and represents the US geographical presence in this transaction.
- Canada – Streamex is a British Columbia corporation, highlighting Canada's involvement in the deal.
Industry
- Medical Technology – BioSig Technologies operates in the medical technology sector, providing insights into the latest innovations in healthcare tech.
- Blockchain and Cryptocurrency – Streamex focuses on tokenization and blockchain, making this sector relevant to the article as it details the company's operations and strategic direction.
- Commodity Markets – The article discusses Streamex's role in bringing commodities, a key component of global markets, on-chain through tokenization.
- Finance – BioSig Technologies' strategic financial maneuver to acquire Streamex underlines the role finance plays in company growth and expansion.
Financials
- 75% – Percentage of BioSig's fully diluted common stock that Streamex shareholders are entitled to receive post-exchange agreement.
- 19.9% – Initial percentage of BioSig common stock that Streamex shareholders will receive pre-transaction approval.
- US$142.85 trillion – Size of the global commodity market which Streamex aims to penetrate through tokenization.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| BioSig Technologies, Inc. | Acquirer | Company | A medical technology company involved in acquiring Streamex to advance its market position. |
| Streamex Exchange Corporation | Target Company | Company | The company being acquired, specializing in tokenization of real-world assets, particularly commodities. |
| Henry McPhie | Incoming CEO of the Combined Company | People | Co-Founder and CEO of Streamex, to lead the combined entity. |
| Morgan Lekstrom | Chairman of the Combined Company | People | Co-Founder and Chairman of Streamex, will be Chairman of the combined company. |
| Anthony Amato | Outgoing CEO of BioSig | People | Current CEO of BioSig, transitioning to the Board of Directors. |
| Frank Giustra | Strategic Investor and Advisor | People | A strategic investor and advisor on commodities, with a significant business background. |
| Mathew August | Strategic Advisor on US Capital Markets | People | A strategic advisor with a background in US capital markets and significant investments in various diversified industries. |
| Mitchell Williams | Strategic Advisor on US Capital Markets | People | A private investment firm managing partner, advising on US capital markets. |